Indoco Remedies is currently trading at Rs. 381.80, up by 2.95 points or 0.78% from its previous closing of Rs. 378.85 on the BSE.
The scrip opened at Rs. 383.40 and has touched a high and low of Rs. 385.30 and Rs. 379.25 respectively. So far 3632 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 529.70 on 12-Aug-2021 and a 52 week low of Rs. 321.05 on 12-May-2022.
Last one week high and low of the scrip stood at Rs. 389.00 and Rs. 353.35 respectively. The current market cap of the company is Rs. 3506.32 crore.
The promoters holding in the company stood at 58.69%, while Institutions and Non-Institutions held 19.42% and 21.89% respectively.
Indoco Remedies had incorporated wholly owned subsidiary namely ‘Warren Remedies’. The company has incorporated wholly owned subsidiary to manufacture of pharmaceutical products. Cost of acquisition is Rs 1 lakh. Warren Remedies is yet to commence its business operations.
Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |